 |
Fixed-dose combination of fosfomycin disodium and tobramycin |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| EU Market Approval | EU |
| EU Designation Date | 2015-08-10 00:00:00 |
| Sponsor | CURx Pharma (UK) Limited |
Related Access Program
| |
Fixed-dose combination of fosfomycin disodium and tobramycin |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| EU Market Approval | EU |
| EU Designation Date | 2015-08-10 00:00:00 |
| Sponsor | CURx Pharma (UK) Limited |